Publications by authors named "Filip Pirsl"

Claim this Profile
D
Distinct Biological Subtypes of Chronic GVHD after Pediatric Hematopoietic Cell Transplantation.
Bernard Ng, Andrew C Harris, Sayeh Abdossamadi, Geraldine Aubert, Rajinder P Bajwa, Filip Pirsl

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.
Bernard Ng, Andrew C Harris, Sayeh Abdossamadi, Madeline P Lauener, Geraldine Aubert, Filip Pirsl

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT.
Eduard Schulz, Lauren M Curtis, Noa G Holtzman, Seth M Steinberg, Kaska Wloka, Filip Pirsl

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of clonal hematopoiesis of indeterminate potential in patients with severe chronic graft-versus-host disease.
Eduard Schulz, Filip Pirsl, Kathy McGraw, Darryl Nousome, Yi Liu

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receipt of Prostate-Specific Antigen Test in Medicaid Beneficiaries With and Without HIV in 2001-2015 in 14 States.
Filip Pirsl, Keri Calkins, Jacqueline E Rudolph, Eryka Wentz, Xiaoqiang Xu

AIDS Res Hum Retroviruses· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
Filip Pirsl, Keri Calkins, Jacqueline E Rudolph, Eryka Wentz, Xiaoqiang Xu

AIDS Care· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.
Noa G Holtzman, Lauren M Curtis, Rachel B Salit, Brian C Shaffer, Filip Pirsl

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.
Filip Pirsl, Jeanne C Keruly, Richard D Moore, Bryan Lau, Corinne E Joshu

Prev Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Colon Cancer Among Medicaid Beneficiaries With or Without Human Immunodeficiency Virus Under Comparable Colorectal Cancer Screening Patterns.
Jacqueline E Rudolph, Keri L Calkins, Xueer Zhang, Yiyi Zhou, Filip Pirsl

Open Forum Infect Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.
Filip Pirsl, Keri Calkins, Jacqueline E Rudolph, Eryka Wentz, Xiaoqiang Xu

medRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience.
Mark C Markowski, Filip Pirsl, Jeanne C Keruly, Geetanjali Chander, Richard D Moore

Prostate Cancer Prostatic Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Red cell distribution width as a new prognostic biomarker in refractory chronic graft--host disease.
Eduard Schulz, Filip Pirsl, Noa G Holtzman, David Beshensky, Edward W Cowen

Haematologica· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower endoscopy, early-onset, and average-onset colon cancer among Medicaid beneficiaries with and without HIV.
Corinne E Joshu, Keri L Calkins, Jacqueline E Rudolph, Xiaoqiang Xu, Eryka Wentz, Filip Pirsl

AIDS· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Cancer Incidence in an Observational Cohort of Medicaid Beneficiaries With and Without HIV, 2001-2015.
Jacqueline E Rudolph, Keri L Calkins, Xiaoqiang Xu, Eryka Wentz, Filip Pirsl

J Acquir Immune Defic Syndr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.
Aaron T Zhao, Filip Pirsl, Seth M Steinberg, Noa G Holtzman, Eduard Schulz

Bone Marrow Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.
David Beshensky, Filip Pirsl, Noa G Holtzman, Seth M Steinberg, Jacqueline W Mays

Bone Marrow Transplant· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus.
Sencer Goklemez, Sarfaraz Hasni, Frances T Hakim, Paolo A Muraro, Filip Pirsl

Rheumatology (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease.
Ana Zelic Kerep, Filip Pirsl, Seth Steinberg, Sandra Mitchell, Lauren Curtis

Hemasphere· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
Sencer Goklemez, Leorey N Saligan, Filip Pirsl, Noa G Holtzman, Alen Ostojic

Bone Marrow Transplant· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subsequent Cancers in Patients Affected with Moderate or Severe Chronic Graft-versus-Host Disease.
Dana A Schaar, Filip Pirsl, Noa Holtzman, Seth M Steinberg, Jeannette Nashed

Transplant Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
Ema Prenc, Drazen Pulanic, Maja Pucic-Bakovic, Ivo Ugrina, Lana Desnica, Filip Pirsl

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
Alexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, Angel Garced, Krishna C Devarasetty, Filip Pirsl

Bone Marrow Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
Alexandra A Pietraszkiewicz, Debbie Payne, Maria Abraham, Angel Garced, Krishna C Devarasetty, Filip Pirsl

Bone Marrow Transplant· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
Claire L Ruben, Filip Pirsl, Seth M Steinberg, Noa G Holtzman, Laura Parsons-Wandell

Bone Marrow Transplant· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Lauren M Curtis, Alen Ostojic, David J Venzon, Noa G Holtzman, Filip Pirsl

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis